Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

IO Biotech, Inc. Logo
Clinical-stage biopharma developing dual-action therapeutic cancer vaccines.
United States of America
IOBT
IONIS PHARMACEUTICALS INC Logo
Biopharmaceutical firm developing RNA- and DNA-targeted therapeutics for serious diseases.
United States of America
IONS
IOVANCE BIOTHERAPEUTICS, INC. Logo
Biopharmaceutical company developing personalized TIL cell therapies for cancer.
United States of America
IOVA
Ipsen Logo
Biopharmaceutical company developing medicines for oncology, rare diseases, and neuroscience.
France
IPN
IRLAB Therapeutics Logo
Develops novel treatments for Parkinson's disease and other CNS disorders.
Sweden
IRLAB
IRONWOOD PHARMACEUTICALS INC Logo
A healthcare company developing and commercializing therapies for GI diseases.
United States of America
IRWD
ISU Abxis Co., Ltd. Logo
Develops antibody-based immunotherapies for oncology and rare diseases.
South Korea
086890
Iterum Therapeutics plc Logo
Develops and commercializes anti-infectives for multi-drug resistant pathogens.
United States of America
ITRM
Jaguar Health, Inc. Logo
Develops plant-based prescription medicines for human and animal GI diseases.
United States of America
JAGX
Janux Therapeutics, Inc. Logo
Develops tumor-activated T cell engager immunotherapies for cancer treatment.
United States of America
JANX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.